drugset / Trial / NCT04203914
Short Term Effect of Empagliflozin in Hypertension
NaSingle-groupOpen-labelTreatment
Summary
The investigators assessed the 6-week effect of once daily 25mg SGLT2-i Empagliflozin on left ventricular diastolic function and blood pressure profile in non diabetic hypertensive patients
Timeline
- Start
- 2017-01-10
- Primary completion
- 2017-05-30
- Completion
- 2017-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 25 mg | — |